25.03.2025 – 08:01ARTTIC Innovation GmbHSGLT2 HYPE: New EU-funded Project Aims to Transform Hypertension TreatmentSGLT2 HYPE websitemehr
12.03.2025 – 12:11GEA Group Aktiengesellschaft2GEA presents the kytero® 10, the world's smallest single use disk stack centrifugeClick here for the GEA media pagemehr
07.03.2025 – 07:31STADA Arzneimittel AG3Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the marketEin Dokumentmehr
14.01.2025 – 11:15Helmholtz MunichSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissuesmehr
19.12.2024 – 11:43RHEACELL GmbH und Co. KGRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcersmehr
16.12.2024 – 10:27Gerresheimer AGGerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*mehr
25.11.2024 – 13:52Helmholtz MunichInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapiesmehr
24.10.2024 – 08:09Ottobock SE & Co. KGaAOttobock invests in NeuroTech company ONWARD® MedicalOttobock Newsroommehr
24.09.2024 – 12:25RHEACELL GmbH und Co. KGRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVUmehr
09.09.2024 – 09:06Sysmex Europe SE2Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.Visit our website!Ein Dokumentmehr
04.09.2024 – 15:13Fördergesellschaft IZB mbH2Record financing rounds at the Munich biotech hubFind out more about the 40+ biotech start-ups at the IZBEin Dokumentmehr
03.09.2024 – 11:10Bosch Healthcare Solutions GmbHNear-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesiimehr
18.07.2024 – 11:05Bosch Healthcare Solutions GmbHPCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of C. difficile, norovirus, and rotavirus at the sampling pointmehr
02.07.2024 – 14:00ARTTIC Innovation GmbHcanSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision OpencanSERV Challenge Calls2 Dokumentemehr
28.05.2024 – 14:05ARTTIC Innovation GmbHcanSERV invites applications for "Revolutionising Cancer Patient Care"canSERV Challenge CallEin Dokumentmehr
28.05.2024 – 14:00ARTTIC Innovation GmbH3canSERV invites applications for "Revolutionising Cancer Patient Care"canSERV CallEin Dokumentmehr
10.04.2024 – 11:00Dr. Reddy's Laboratories SADr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatmentmehr
13.03.2024 – 16:21FDX Fluid Dynamix GmbH4FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiXmehr
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘mehr
28.02.2024 – 11:07Helmholtz MunichRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmehr
23.02.2024 – 10:28Leipzig Tourismus und Marketing GmbH5Pioneering Heart Surgery and Medical Congresses in LeipzigEin Dokumentmehr
22.02.2024 – 13:23Helmholtz MunichTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical TrialMore information on the therapeutic vaccine TherVacBmehr
19.02.2024 – 17:05Helmholtz MunichWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and ComplicationsLearn more about research at Helmholtz Munichmehr
18.01.2024 – 10:00ARTTIC Innovation GmbH2OPTIMA cancer project announces the Region Uppsala as new partnerCheck out the OPTIMA Videomehr
12.10.2023 – 14:01ARTTIC Innovation GmbH3EU Provides 1 Mio. to Researchers to Advance Personalised OncologycanSERV CallEin Dokumentmehr
07.09.2023 – 08:38OD-OS GmbHOD-OS GmbH at ESCRS 2023: Recent MDR certification of Navilas® underlines its advanced standard in retina lasers and opens path to new developmentsmehr
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsEin Dokumentmehr